Navigation Links
Wyeth Wins Philadelphia Diet Drug Trial Involving Claim of PPH
Date:10/10/2008

MADISON, N.J., Oct. 10 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) announced today that the jury in the case of Danny Crowder (Individually and as Administrator of the Estate of Edna Faye Crowder) v. Wyeth in the Philadelphia Court of Common Pleas found in favor of Wyeth.

"We believe this unanimous verdict was supported by the evidence," says Bob Nicholas, an attorney from Reed Smith, who represented Wyeth. "While Mrs. Crowder's death was tragic, the medical evidence clearly demonstrated that her condition was unrelated to the diet drugs she used over ten years ago."

The trial began on September 29, 2008 before The Honorable Gary S. Glazer. The plaintiff alleged the wrongful death of Mrs. Crowder caused by Primary Pulmonary Hypertension (PPH) as a result of her use of the diet drug Pondimin(R), a drug once marketed by Wyeth. The Court had earlier ruled that plaintiff could not pursue punitive damages in this case.

The plaintiff was represented by the Clark Burnett law firm of Houston, Texas.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Wyeth Announces Increase in Common Stock Dividend
2. Retrospective Analysis of Phase 3 Data Suggest Wyeths Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
3. Wyeth Sets Webcast And Conference Call for 2008 Third Quarter Earnings
4. Cyprus and Ireland Add Wyeths 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules
5. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
6. Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
7. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
8. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
9. Wyeth Declares Common and Preferred Stock Dividends
10. Wyeth Pharmaceuticals Announces Organizational Change
11. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , April 27, 2016 ... research report with specific focus on US, EU, ... Japan , to the healthcare business intelligence ... library. Complete report on the Flow ... companies and supported with 282 tables and figures ...
(Date:4/26/2016)... , ... April 26, 2016 , ... ... lithography systems, announces the latest technology innovation for its Volume Pattern Generator (VPG) ... demand for production of advanced photomasks as well as a solution for mid ...
(Date:4/26/2016)... ... April 26, 2016 , ... Seattle based non-profit, ... grant from 1Plus12 Corporation. The grant will be used to further the scientific ... the organization's website http://www.ivsci.org , In accounting the grant to the ...
(Date:4/26/2016)... , April 26, 2016 genae, ... the medical industries, announced today the appointment of Prof. ... Officer. Prof. Balzer,s responsibilities will include all clinical, safety ... "We feel privileged and honored with the acceptance ... Bart Segers , CEO at genae. "Prof. Balzer,s impressive ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):